the treatment consisted of aminohydroxybutylidene diphosphonate , 2.5 mg/d intravenously for five days , or dichloromethylene diphosphonate , 300 mg/d intravenously for seven days , followed by 100 mg/d intramuscularly for ten days .
C0012544
diphosphonate
C0012081
dichloromethylene diphosphonate